Ted C. Nark - 08 May 2022 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role
Director
Signature
/s/ Meredith Cook, Attorney-in-Fact
Issuer symbol
AMRX
Transactions as of
08 May 2022
Transactions value $
$0
Form type
4
Filing time
10 May 2022, 18:48:02 UTC
Previous filing
07 May 2021
Next filing
11 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Options Exercise +35.4K +32.55% 144K 08 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRX Restricted Stock Units Options Exercise $0 -35.4K -100% $0.00* 0 08 May 2022 Class A Common Stock 35.4K Direct F1, F2
transaction AMRX Restricted Stock Units Award $0 +80.1K $0.00 80.1K 09 May 2022 Class A Common Stock 80.1K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2 On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022.
F3 Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.